HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Larazotide

HCID 9810532
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
258818-34-7
Standard SMILES
CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C
InChIKey
ORFLZNAGUTZRLQ-ZMBVWFSWSA-N
Molecular formula
C32H55N9O10
Average molar mass
725.8 g/mol
Monoisotopic mass
725.40718899

Overview

Larazotide is an oligopeptide.

Names & identifiers

Preferred name
Larazotide
IUPAC
2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]acetic acid
English name
Larazotide
Molecular formula
C32H55N9O10
Molecular weight
725.83

Names & synonyms

Larazotide258818-34-7LarazotidaLarazotide [USAN:INN]AT-2347AT 2347ZN3R5560ZVDTXSID30180526glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolylglycine2-{[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-methylbutanamido]-4-methylpentanamido]-3-methylbutanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}acetic acidlarazotidum2-(((2S)-1-((2S)-2-((2S)-2-((2S)-2-((2S)-2-(2-(2-aminoacetamido)acetamido)-3-methylbutanamido)-4-methylpentanamido)-3-methylbutanamido)-4-carbamoylbutanoyl)pyrrolidin-2-yl)formamido)acetic acid
Show more names
AT2347Unii-zn3R5560zvLarazotide (Larizoline)Gly-Gly-Val-Leu-Val-Gln-Pro-Gly
Larazotide [INN]RefChem:798506LARAZOTIDE [USAN]LARAZOTIDE [WHO-DD]DTXCID70103017Glycine, glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolyl-2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]acetic acid2-((S)-1-((2S,5S,8S,11S)-17-Amino-2-(3-amino-3-oxopropyl)-8-isobutyl-5,11-diisopropyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaheptadecan-1-oyl)pyrrolidine-2-carboxamido)acetic acid

Properties

Computed structural propertiesFilling in

XLogP
-3.6
Topological polar surface area
301 Ų
Hydrogen bond donors
9
Hydrogen bond acceptors
11
Rotatable bonds
21
Heavy atoms
51
Formal charge
0
Complexity
1,290

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15

Physicochemical properties

Density
1.254 · 1.254
storage temp.
-20 °C · Store at -20°C
solubility
DMSO: Insoluble;Ethanol: Insoluble
form
Solid
color
White to off-white
Water Solubility
25 mg/mL · Water: 25 mg/mL (34.44 mM)
Sequence
H-Gly-Gly-Val-Leu-Val-Gln-Pro-Gly-OH
FDA UNII
3 R5560ZV · ZN3R5560ZV

Chemistry & industry

Pharmacology

Mechanism of Action · 1 item

AT-1001 is an orally administered octapeptide zonulin receptor antagonist that appears to exert its inhibitory effect on gliadin-induced tight junction disassembly by blocking putative zonulin receptors on the luminal surface of the small intestine.

Applications · 1 item

UsesLarazotideis a peptide which is an orally active zonulin antagonist. Larazotide shows antiviral activity to varicella-zoster virus (VZV) with EC50s of 44.14 and 59.06 μM for strain OKA and 07-1, respectively. Larazotide can be used for the research of celiac disease and infection[1][2].

Additional notes

DefinitionChEBI: Larazotide is an oligopeptide.

Related reactions

2 records
New reaction record
HRID 2172175 reaction equation
HRID 2172175As product
HRID 2172176 reaction equation
HRID 2172176As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
258818-34-7
PubChem CID
9810532
DTXSID
DTXSID30180526
ChEMBL
CHEMBL2105646
ChEBI
CHEBI:177799
Nikkaji
J3.802.386A